Meningoencephalomyelitis caused by Pasteurella multocida in a cat.
Messer
Jeannette S
JS
Department of Veterinary Clinical Sciences, The Ohio State University, Columbus, USA. messer.55@osu.edu
Kegge
Samantha J
SJ
Cooper
Edward S
ES
Colitz
Carmen M H
CM
Abramson
Carley J
CJ
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000969:Antinematodal Agents / Q000627:therapeutic use; D002371:Cat Diseases / Q000188:drug therapy / Q000382:microbiology*; D002415:Cats; D002442:Ceftazidime / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005273:Fenbendazole / Q000627:therapeutic use; D008590:Meningoencephalitis / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D010326:Pasteurella Infections / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D016979:Pasteurella multocida / Q000302:isolation & purification*; D013411:Sulfadiazine / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D000096926:Benzenesulfonamides
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000969:Antinematodal Agents; D002442:Ceftazidime; D003907:Dexamethasone; D004338:Drug Combinations; D005273:Fenbendazole; D013411:Sulfadiazine; D014295:Trimethoprim; C024873:sulfadiazine, trimethoprim drug combination; D000096926:Benzenesulfonamides